McKesson stock edges lower ahead of the opening bell

At the close on September 11, 2026, McKesson stock finished at USD 880.52 on the NYSE, down 0.04%. The shares traded between USD 874.31 and USD 893.92, while the broader market also eased. Today, investors track McKesson at a major healthcare conference.

McKesson stock closed at USD 880.52 on the NYSE on September 11, 2026, slipping 0.04% from the prior session. Per MarketBeat data, the shares moved within a relatively tight intraday range compared with their recent performance.

September 11, 2026 in numbers

McKesson Corporation Inc. (ISIN US58155Q1031, NYSE: MCK) finished the last session at USD 880.52, with the quoted range for the day between USD 874.31 and USD 893.92 on September 11, 2026, according to MarketBeat pricing data from the NYSE close. The recorded trading volume of 888,793 shares modestly exceeded the recent average volume of 850,035 shares for the stock, indicating slightly higher turnover on the day.

At this closing level, McKesson remained within its 52-week range of USD 687.68 to USD 999.00, staying closer to the upper portion of that band based on the same MarketBeat overview. The move of negative 0.04% on September 11, 2026 was comparatively small against the stock’s year-to-date gain, with MarketBeat noting that McKesson had risen from USD 820.18 at the start of 2026 to around USD 880.52, a 7.4% increase over that period.

Today’s drivers and events

The news flow around McKesson remained active into the end of last week, with several items contributing to investor attention even though no single release clearly dominated the price action. On September 10, 2026, a market commentary highlighted that McKesson suffered a larger drop than the general market, framing the stock’s recent volatility in the broader context of healthcare names, as reported by Yahoo Finance. In addition, McKesson’s participation in investor events has kept the stock on analysts’ radar; the company presented at the Wells Fargo 21st Annual Healthcare Conference earlier in the week, as documented by Seeking Alpha, reinforcing ongoing dialogue between management and institutional investors.

Looking ahead to today, McKesson is scheduled to be represented at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026, according to the company calendar displayed by MarketBeat. This high-profile event gathers major healthcare companies and investors, and McKesson’s appearance can shape sentiment by providing updated commentary on strategy, capital allocation, and industry trends. Beyond company-specific news, broader market conditions also frame today’s session: U.S. equity futures pointed to a softer start for the Nasdaq 100 and other benchmarks on September 14, 2026 in the pre-market overview from Yahoo Finance, an environment that can influence trading in large healthcare distributors like McKesson even in the absence of fresh company-specific earnings or guidance updates today.